Details for New Drug Application (NDA): 017612
✉ Email this page to a colleague
The generic ingredient in LO/OVRAL is ethinyl estradiol; norgestrel. There are twenty-six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestrel profile page.
Summary for 017612
Tradename: | LO/OVRAL |
Applicant: | Cadence Health |
Ingredient: | ethinyl estradiol; norgestrel |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL-21 | Strength | 0.03MG;0.3MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes |
Expired US Patents for NDA 017612
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Cadence Health | LO/OVRAL | ethinyl estradiol; norgestrel | TABLET;ORAL-21 | 017612-001 | Approved Prior to Jan 1, 1982 | ⤷ Subscribe | ⤷ Subscribe |
Cadence Health | LO/OVRAL | ethinyl estradiol; norgestrel | TABLET;ORAL-21 | 017612-001 | Approved Prior to Jan 1, 1982 | ⤷ Subscribe | ⤷ Subscribe |
Cadence Health | LO/OVRAL | ethinyl estradiol; norgestrel | TABLET;ORAL-21 | 017612-001 | Approved Prior to Jan 1, 1982 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription